1. Claus O Wilke
  2. Sara L Sawyer  Is a corresponding author
  1. The University of Texas at Austin, United States
  2. University of Colorado Boulder, United States

A long-standing quest in evolutionary biology has been to identify the mechanisms that cause genomes to change and diversify over time. One celebrated theory, the neutral theory, argues that the vast majority of mutations found in genomes are of no consequence, and that mutations persist entirely by random chance (Kimura, 1983). Alternatively, mutations may persist because they are adaptive; that is, the organism is better off having the mutation than not. Now, in eLife, David Enard, Le Cai, Carina Gwennap and Dmitri Petrov from Stanford University argue that viruses are one of the major drivers of adaptive mutations in the human genome and in mammalian genomes in general (Enard et al., 2016).

Enard et al. examined patterns of molecular evolution in human proteins, comparing the patterns in proteins that interact with viruses to those that do not. How do we know which human proteins interact with viruses? Since this information is not readily available, Enard et al. had to manually search the literature and read thousands of articles to build their data set. They started out with a list of 9,861 human proteins and then searched for all articles that mentioned one of the proteins as well as the word “virus.” Each article was then examined to determine whether it established a physical interaction between the human protein and either a viral protein, viral RNA or viral DNA. This procedure yielded a final list of 1,256 proteins that physically interact with viruses. The remaining proteins in the list were used as a control group, serving as point of comparison.

To assess the extent of adaptation in these proteins, Enard et al. used a test that compares patterns of mutations in the DNA sequences that encode the proteins (McDonald and Kreitman, 1991). This test separates mutations into four different types. First, it defines substitutions as those shared by all individuals in a population, and polymorphisms as those only present in some individuals. Furthermore, mutations can occur at “functional” sites, where they can modify the protein that gets expressed, or at “neutral” sites, where they have no effect on the final protein. Under the neutral theory, we expect the ratio of functional versus neutral mutations to be the same whether we are considering substitutions or polymorphisms (Figure 1A). Conversely, if some functional mutations are adaptive and result in increased fitness, then natural selection will have acted to drive an increase in the frequency of functional mutations until they are shared by all individuals. In this case, the ratio of functional versus neutral mutations will be greater for substitutions than it will be for polymorphisms (Figure 1B). More importantly for the study by Enard et al., the two ratios can also be used to estimate the fraction of substitutions driven by adaptation (Smith and Eyre-Walker, 2002).

Two theories are diagrammed, neutral evolution and adaptive evolution.

These theories describe how genetic mutations persist in the genome, leading to the development of new traits in a species. To differentiate between these two theories, the McDonald–Kreitman approach estimates the amount of adaptive evolution in diverging populations. This method involves comparing two ratios: d/d0, which is the number of substitutions at functional sites in a protein’s DNA sequence (d; green squares) divided by the number of substitutions at neutral sites (d0; light blue squares); and p/p0, which is the number of polymorphisms at functional sites (p; green circles) divided by the number of polymorphisms at neutral sites (p0; light blue circles). These two ratios can also be used to estimate the fraction (α) of substitutions driven by adaptation, via the formula α = 1 – (d0/d)(p/p0). (A) Under neutral evolution, we assume that all mutations at neutral sites have no effect on how the resulting protein works and that all mutations at functional sites either have no effect or are strongly deleterious. In this case, d/d0 = p/p0, and α = 0. (B) Under adaptive evolution, there is an excess of substitutions at functional sites relative to the number of polymorphisms seen at functional sites, i.e., d/d0 > p/p0. In this case, α > 0.

Enard et al. find that at least 30% of the adaptive mutations that have accumulated in human genes seem to have arisen because they offer protection against viral infection. This conclusion is based on the fact that more adaptive substitutions were found in the subset of proteins that interact with viruses than in the control set of proteins that do not. The fact that so much human evolution has been focused on proteins that interact with viruses affirms what we already knew: viruses have historically been one of our biggest causes of death and disease, if not the biggest cause. They, not lions, tigers or bears, sit masterfully above us on the food chain of life, occupying a role as alpha predators who prey on everything and are preyed upon by nothing.

One seemingly puzzling result from the study is that the human proteins that interact with viruses are more evolutionarily conserved than other proteins, yet also experience more adaptive evolution. However, this can be explained by considering where the adaptive mutations occur. Viruses may evolve to interact with the conserved and essential proteins of their hosts because targeting those proteins makes it easier for the viruses to infect all individuals within a species. This may also help the viruses to infect individuals of a new species. But unfortunately for the viruses, interacting with a host protein may promote adaptive mutations at the virus-binding surface of the protein, eventually preventing the viral interaction. This selection pressure creates a hotspot of adaptive evolution in a protein that is otherwise highly conserved.

The work by Enard et al. is conservative; it likely underestimates the total amount of selection due to viruses. As the authors point out, their list of virus-interacting proteins is only a subset of the actual virus-interacting proteins encoded by the human genome. We typically only know that a protein interacts with a virus if the virus causes a significant disease burden and is well-studied, such as HIV or influenza virus. There are, however, many other unknown viruses that we encounter every day through processes such as eating and breathing. An extensive network of proteins protects us from these viruses, but the proteins in this network are difficult to identify because they act silently, protecting us so successfully that no disease results. New human viruses such as Ebola, Zika and MERS arise when one of these environmental viruses evolves to circumvent this invisible shield. In this way, diverse human proteins are engaged in a silent battle with viruses every single day.

References

Article and author information

Author details

  1. Claus O Wilke

    Department of Integrative Biology, The University of Texas at Austin, Austin, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7470-9261
  2. Sara L Sawyer

    Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, United States
    For correspondence
    ssawyer@colorado.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6965-1085

Publication history

  1. Version of Record published: May 17, 2016 (version 1)
  2. Version of Record updated: May 18, 2016 (version 2)

Copyright

© 2016, Wilke et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,953
    views
  • 556
    downloads
  • 12
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Claus O Wilke
  2. Sara L Sawyer
(2016)
Adaptive Evolution: At the mercy of viruses
eLife 5:e16758.
https://doi.org/10.7554/eLife.16758
  1. Further reading

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup ... Christian Kroun Damgaard
    Research Article

    Circular RNAs represent a class of endogenous RNAs that regulate gene expression and influence cell biological decisions with implications for the pathogenesis of several diseases. Here, we disclose a novel gene-regulatory role of circHIPK3 by combining analyses of large genomics datasets and mechanistic cell biological follow-up experiments. Using time-course depletion of circHIPK3 and specific candidate RNA-binding proteins, we identify several perturbed genes by RNA sequencing analyses. Expression-coupled motif analyses identify an 11-mer motif within circHIPK3, which also becomes enriched in genes that are downregulated upon circHIPK3 depletion. By mining eCLIP datasets and combined with RNA immunoprecipitation assays, we demonstrate that the 11-mer motif constitutes a strong binding site for IGF2BP2 in bladder cancer cell lines. Our results suggest that circHIPK3 can sequester IGF2BP2 as a competing endogenous RNA (ceRNA), leading to target mRNA stabilization. As an example of a circHIPK3-regulated gene, we focus on the STAT3 mRNA as a specific substrate of IGF2BP2 and validate that manipulation of circHIPK3 regulates IGF2BP2-STAT3 mRNA binding and, thereby, STAT3 mRNA levels. Surprisingly, absolute copy number quantifications demonstrate that IGF2BP2 outnumbers circHIPK3 by orders of magnitude, which is inconsistent with a simple 1:1 ceRNA hypothesis. Instead, we show that circHIPK3 can nucleate multiple copies of IGF2BP2, potentially via phase separation, to produce IGF2BP2 condensates. Our results support a model where a few cellular circHIPK3 molecules can induce IGF2BP2 condensation, thereby regulating key factors for cell proliferation.

    1. Cell Biology
    2. Computational and Systems Biology
    N Suhas Jagannathan, Javier Yu Peng Koh ... Lisa Tucker-Kellogg
    Research Article

    Bats have unique characteristics compared to other mammals, including increased longevity and higher resistance to cancer and infectious disease. While previous studies have analyzed the metabolic requirements for flight, it is still unclear how bat metabolism supports these unique features, and no study has integrated metabolomics, transcriptomics, and proteomics to characterize bat metabolism. In this work, we performed a multi-omics data analysis using a computational model of metabolic fluxes to identify fundamental differences in central metabolism between primary lung fibroblast cell lines from the black flying fox fruit bat (Pteropus alecto) and human. Bat cells showed higher expression levels of Complex I components of electron transport chain (ETC), but, remarkably, a lower rate of oxygen consumption. Computational modeling interpreted these results as indicating that Complex II activity may be low or reversed, similar to an ischemic state. An ischemic-like state of bats was also supported by decreased levels of central metabolites and increased ratios of succinate to fumarate in bat cells. Ischemic states tend to produce reactive oxygen species (ROS), which would be incompatible with the longevity of bats. However, bat cells had higher antioxidant reservoirs (higher total glutathione and higher ratio of NADPH to NADP) despite higher mitochondrial ROS levels. In addition, bat cells were more resistant to glucose deprivation and had increased resistance to ferroptosis, one of the characteristics of which is oxidative stress. Thus, our studies revealed distinct differences in the ETC regulation and metabolic stress responses between human and bat cells.